Shares of Pharmaceutical Preparations company Eli Lilly and Company climbed 1.34% this afternoon. Here are some quick facts to get you started if you are interested in the stock:
-
Eli Lilly and Company has logged a 26.31% 52 week change, compared to -9.49% for the S&P 500
-
LLY has an average analyst rating of buy and is -17.78% away from its mean target price of $383.62 per share
-
Its trailing earnings per share (EPS) is $6.9, which brings its trailing Price to Earnings (P/E) ratio to 45.71. The Basic Materials sector's average P/E ratio is 10.03
-
The company's forward earnings per share (EPS) is $11.74 and its forward P/E ratio is 26.87
-
The company has a Price to Book (P/B) ratio of 34.06 in contrast to the Basic Materials sector's average P/B ratio is 2.08
-
The current ratio is currently 1.05, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
The company's free cash flow for the last fiscal year was $5,230,100,000.00 and the average free cash flow growth rate is 4.46%
-
Eli Lilly and Company's revenues have an average growth rate of 6.0% with operating expenses growing at 5.68%. The company's current operating margins stand at 1.98%